X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
palbociclib (549) 549
oncology (341) 341
index medicus (321) 321
breast cancer (287) 287
humans (212) 212
female (162) 162
combination (153) 153
endocrine therapy (143) 143
letrozole (132) 132
fulvestrant (130) 130
cancer (127) 127
abemaciclib (122) 122
breast neoplasms - drug therapy (111) 111
ribociclib (109) 109
metastasis (104) 104
cyclin-dependent kinase 4 - antagonists & inhibitors (103) 103
therapy (103) 103
cyclin-dependent kinase 6 - antagonists & inhibitors (94) 94
cell cycle (91) 91
cyclin-dependent kinases (87) 87
cdk4 (86) 86
cyclin-dependent kinase 4 (82) 82
chemotherapy (81) 81
breast neoplasms - pathology (71) 71
care and treatment (71) 71
dependent kinase 4/6 (70) 70
double-blind (67) 67
postmenopausal women (67) 67
breast-cancer (66) 66
tumors (63) 63
1st-line treatment (62) 62
analysis (62) 62
animals (62) 62
clinical trials (62) 62
pd 0332991 (60) 60
pharmacology & pharmacy (60) 60
cancer therapies (58) 58
patients (57) 57
phase-i (57) 57
medicine & public health (56) 56
metastases (55) 55
erbb-2 protein (52) 52
cell biology (51) 51
cyclin-dependent kinase (51) 51
kinases (51) 51
middle aged (51) 51
piperazines - pharmacology (51) 51
pyridines - pharmacology (51) 51
resistance (51) 51
article (50) 50
research (50) 50
survival (49) 49
estrogen (48) 48
cdk4/6 inhibitors (47) 47
cell line, tumor (47) 47
cell-cycle (47) 47
epidermal growth factor (47) 47
expression (47) 47
metastatic breast cancer (47) 47
aged (46) 46
piperazines - therapeutic use (46) 46
pyridines - therapeutic use (46) 46
antineoplastic agents - therapeutic use (45) 45
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
protein kinase inhibitors - pharmacology (44) 44
phosphorylation (43) 43
adult (42) 42
protein kinase inhibitors - therapeutic use (42) 42
women (42) 42
breast neoplasms - metabolism (41) 41
health aspects (41) 41
treatment outcome (41) 41
kinase 4/6 inhibitor (40) 40
cdk4/6 inhibitor (38) 38
inhibitors (38) 38
drug therapy (37) 37
mice (37) 37
neoplasms. tumors. oncology. including cancer and carcinogens (37) 37
advanced breast cancer (36) 36
cdk4/6 (36) 36
neutropenia (36) 36
obstetrics & gynecology (36) 36
antineoplastic agents - pharmacology (35) 35
multicenter (35) 35
receptors, estrogen - metabolism (35) 35
apoptosis (34) 34
toxicity (34) 34
piperazines - administration & dosage (33) 33
pyridines - administration & dosage (33) 33
trial (33) 33
womens health (32) 32
cell proliferation (31) 31
review (31) 31
tamoxifen (31) 31
antitumor-activity (30) 30
endocrine resistance (30) 30
inhibition (30) 30
placebo (30) 30
receptor, erbb-2 - metabolism (30) 30
anastrozole (29) 29
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 02/2019, Volume 17, Issue 2, pp. 190 - 192
Journal Article
ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 02/2017, Volume 40, Issue 1-2, pp. 67 - 67
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 24, pp. 2465 - 2472
PurposeThis phase III study evaluated ribociclib plus fulvestrant in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative... 
TRIAL | DOUBLE-BLIND | PALBOCICLIB | ENDOCRINE THERAPY | ONCOLOGY | TUMORS
Journal Article
Annals of Oncology, ISSN 0923-7534, 07/2018, Volume 29, Issue 7, pp. 1541 - 1547
Abstract Background The phase III MONALEESA-2 study demonstrated significantly prolonged progression-free survival (PFS) and a manageable toxicity profile for... 
Advanced breast cancer | Ribociclib | CDK4/6 inhibitor | PALBOCICLIB | THERAPY | ONCOLOGY | advanced breast cancer | ribociclib
Journal Article
ONKOLOGE, ISSN 0947-8965, 07/2016, Volume 22, Issue 7, pp. 507 - 508
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article
ONCOLOGIST, ISSN 1083-7159, 06/2017, Volume 22, Issue 6, pp. 755 - 755
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2016, Volume 14, Issue 5.5, pp. 641 - 644
The updates to management of early invasive breast cancer in 2016 are minor but have important treatment implications for patients. The NCCN Guidelines Panel... 
IRRADIATION | PALBOCICLIB | MULTICENTER | TRASTUZUMAB | ONCOLOGY | OPEN-LABEL
Journal Article
Oncologist, ISSN 1083-7159, 2019, p. theoncologist.2019-0019
PALOMA-2 confirmed that first-line palbociclib + letrozole improved progression-free survival (hazard ratio, 0.58; 95% confidence interval, 0.46-0.72) in... 
Hematologic | Breast cancer | Safety | Palbociclib | Neutropenia
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2017, Volume 35, Issue 25, pp. 2857 - 2859
Journal Article
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 08/2015, Volume 107, Issue 8
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2016, Volume 6, Issue 4, pp. 353 - 367
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2017, Volume 15, Issue 5.5, pp. 679 - 681
The management of advanced hormone receptor positive disease has evolved with the emergence of CDK4/6 inhibitors. Improvements in progression-free survival of... 
PALBOCICLIB | WOMEN | ONCOLOGY | LETROZOLE | INHIBITOR
Journal Article
The Breast, ISSN 0960-9776, 02/2019, Volume 43, pp. 8 - 17
Metastatic or advanced breast cancer (mBC/ABC) remains incurable despite many different systemic treatment options. Hormone receptor positive (HR+) disease... 
CDK4/6 signaling pathway | Abemaciclib | Advanced breast cancer | Palbociclib | Ribociclib | Biomarkers | Metastatic breast cancer | Inhibitors of CDK4/6 | 1ST-LINE TREATMENT | PLUS PALBOCICLIB | ENDOCRINE THERAPY | PHASE-II | RECEPTOR | INHIBITOR PALBOCICLIB | OBSTETRICS & GYNECOLOGY | DEPENDENT KINASE 4/6 | ONCOLOGY | STRUCTURAL BASIS | CELL-CYCLE | PD 0332991
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 02/2018, Volume 25, Issue 2, pp. 123 - 130
The purpose of the study was to test the efficacy of neoadjuvant palbociclib therapy and to evaluate its impact on cell cycle arrest and changes in EndoPredict... 
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2019, Volume 37, Issue 14, pp. 1148 - 1148
Journal Article
Japanese Journal of Cancer and Chemotherapy, ISSN 0385-0684, 10/2018, Volume 45, Issue 10, pp. 1498 - 1500
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2018, Volume 167, Issue 3, pp. 607 - 614
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.